Arca
Skip to content
Tools
Tools

Vascular inflammation

Drug research and approvals for vascular inflammation: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 165 studies of vascular inflammation are recruiting on ClinicalTrials.gov, and Health Canada has authorized 8 drug trials for it since 2013.

  • Recruiting worldwide: 165
  • Trials authorized in Canada: 8
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 165 recruiting on ClinicalTrials.gov ↗

Trials authorized in Canada

Newest first; search them all in Canada trials
Nov 25, 2025A randomized, double blind, placebo controlled phase 4 clinical trial to evaluate the long-term safety and efficacy of avacopan in participants with…Avacopan (amg 569)AmgenPending
Jun 4, 2025The restart trial: reducing systemic inflammation for people on antiretroviral therapyFostemsavirSanté Québec- Centre Hospitalier De L’université De MontréalPending
Feb 13, 2023Canagliflozin targeting vascular inflammation: an ottawa imaging study (cantor sing) - a pilot studyCanagliflozin / 18F-fluorodeoxyglucose (18-FDG)Ottawa Heart Institute Research CorporationOngoing
Nov 29, 2022Low dose naltrexone to improve physical health in patients with vasculitis (lodonavasc)NaltrexonePeter MerkelOngoing
Mar 19, 2020Arterial inflammation as a risk factor for cardiovascular disease and its prevention through a polyphenol-rich diet: contribution of quantitative tep/tdm…Chus naf / CyclodxCiusss De L'Estrie - Centre Hospitalier Universitaire De SherbrookePending
Feb 26, 2019Colchicine for prevention of vascular inflammation in non-cardioembolic stroke ¿ a randomised clinical trial of low-dose colchicine for secondary prevention…ColchicineUniversity College DublinPending
Nov 13, 2014A randomized, double-blind, placebo-controlled, dose assessment phase 2 study to evaluate the safety and efficacy of CCX168 in subjects with anti-neutrophil…CCX168/ Rituximab/ CyclophosphamideAmgenClosed
Dec 30, 2013A randomized, double-blind placebo-controlled study to evaluate the effects of colchicine on vascular inflammation as assessed with positron emission…Colchicine /[18F]-fluorodeoxyglucose (18-FDG)Montreal Heart InstituteOngoing

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.